Operating Lease, Right-of-Use Asset of Quince Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Quince Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Quince Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $481,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Quince Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $481,000 -$78,000 -14% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $507,000 -$47,000 -8.5% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $493,000 -$5,000 -1% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $498,000 +$113,000 +29% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $559,000 +$511,000 +1065% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $554,000 +$444,000 +404% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $498,000 +$327,000 +191% 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $385,000 +$94,000 +32% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $48,000 -$160,000 -77% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $110,000 -$218,000 -66% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $171,000 -$172,000 -50% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $291,000 -$874,000 -75% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $208,000 -$1,144,000 -85% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $328,000 -$1,168,000 -78% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $343,000 -$157,000 -31% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,165,000 +$491,000 +73% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $1,352,000 +$504,000 +59% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $1,496,000 +$810,000 +118% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $500,000 -$137,000 -22% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $674,000 +$49,000 +7.8% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $848,000 +$124,000 +17% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $686,000 -$137,000 -17% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $637,000 -$178,000 -22% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $625,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $724,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $823,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $815,000 31 Mar 2019 10-Q 12 Jun 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.